Mindfulness-based intervention for hypertension patients with depression and/or anxiety in the community: a randomized controlled trial.
Study Goal
The researchers aimed to evaluate the effectiveness of a mindfulness-based intervention in reducing depression/anxiety symptoms and blood pressure in hypertensive patients with comorbid depression/anxiety.
Results Summary
The mindfulness intervention significantly reduced depression/anxiety scores (21.1% and 17.8%, respectively) and systolic blood pressure (12.24 mm Hg), while also improving self-efficacy and awareness of physical and mental health compared to the control group.
Population
Sixty hypertensive patients with depression and/or anxiety (intervention group: 8 men, 22 women, mean age 60.02 years; control group: 14 men, 16 women, mean age 57.68 years).
Effective Dosage
Not specified
Duration
10 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based intervention | decrease | depression PHQ-9 scores | hypertension patients with depression/anxiety | 21.1% | reduced | #1 |
mindfulness-based intervention | decrease | anxiety GAD-7 scores | hypertension patients with depression/anxiety | 17.8% | reduced | #2 |
mindfulness-based intervention | decrease | anxiety/stress | hypertension patients with depression/anxiety | - | significant reduction | #3 |
mindfulness-based intervention | decrease | systolic blood pressure | hypertension patients with depression/anxiety | 12.24 mm Hg | reduction | #4 |
mindfulness-based intervention | increase | self-efficacy score | hypertension patients with depression/anxiety | - | significantly improved | #5 |
mindfulness-based intervention | increase | awareness of physical and mental health | hypertension patients with depression/anxiety | - | significantly improved | #6 |
mindfulness-based, short-term focused interventions | decrease | depression and/or anxiety | hypertension patients with depression/anxiety | - | provide modest relief | #7 |
mindfulness-based, short-term focused interventions | decrease | blood pressure | hypertension patients with depression/anxiety | - | effective in lowering | #8 |
mindfulness-based, short-term focused interventions | increase | self-efficacy scores | hypertension patients with depression/anxiety | - | improving | #9 |
OBJECTIVE: To evaluate mindfulness-based intervention for hypertension with depression and/or anxiety. METHODS: 10-week mindfulness-based intervention, including health education for hypertension, exclusively for the control group, was administered to the intervention group to assist sixty hypertension patients with depression/anxiety. Among them, the intervention group comprised 8 men and 22 women, with a mean age of 60.02 years and a mean duration of hypertension of 6.29 years. The control group consisted of 14 men and 16 women with a mean age of 57.68 years and a mean duration of hypertension of 6.32 years. The severity of depressive and/or anxiety symptoms was assessed using the 9-item Patient Health Questionnaire (PHQ-9) and the 7-item Generalized Anxiety Disorder scale (GAD-7), along with blood pressure (BP) measurements taken twice daily. The study utilized a self-made self-efficacy scale and awareness of physical and mental health to evaluate mental health and state. RESULTS: The depression PHQ-9 or GAD-7 scores reduced by 21.1% or 17.8% in the mindfulness-based intervention group, compared to the control (Z = -2.040, P = 0.041) post 10-week period, suggesting significant reduction in anxiety/stress. These results were consistent with a reduction in systolic BP of 12.24 mm Hg (t = 6.041, P = 0.000). The self-efficacy score of the mindfulness intervention group significantly improved compared to the control (t = 7.818, P < 0.001), while the awareness of physical and mental health in the mindfulness intervention group significantly improved compared to the control (χ2 = 5.781, P = 0.016). CONCLUSION: Mindfulness-based, short-term focused interventions provide modest relief for depression and/or anxiety and are effective in lowering blood pressure and improving self-efficacy scores. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR1900028258. Registered 16 December 2019, https://www.chictr.org.cn/showproj.html?proj=43627 .